Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Diseases, Metabolic | 2 | 2014 | 19 | 0.550 |
Why?
|
| Tai Ji | 2 | 2014 | 28 | 0.540 |
Why?
|
| Patient Compliance | 2 | 2018 | 349 | 0.520 |
Why?
|
| Aging | 5 | 2020 | 710 | 0.500 |
Why?
|
| Hearing Disorders | 1 | 2014 | 7 | 0.470 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
| Patient Selection | 2 | 2014 | 466 | 0.450 |
Why?
|
| Longitudinal Studies | 12 | 2020 | 1188 | 0.450 |
Why?
|
| Community Health Services | 1 | 2014 | 120 | 0.420 |
Why?
|
| Postmenopause | 1 | 2014 | 224 | 0.420 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 57 | 0.400 |
Why?
|
| Environmental Exposure | 1 | 2013 | 209 | 0.360 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 309 | 0.340 |
Why?
|
| Desogestrel | 1 | 2008 | 4 | 0.300 |
Why?
|
| Contraceptive Agents, Female | 1 | 2008 | 24 | 0.290 |
Why?
|
| Wisconsin | 4 | 2014 | 17 | 0.280 |
Why?
|
| Olfaction Disorders | 2 | 2019 | 11 | 0.260 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2019 | 48 | 0.250 |
Why?
|
| Aged | 14 | 2020 | 13426 | 0.240 |
Why?
|
| Cognition | 2 | 2020 | 455 | 0.230 |
Why?
|
| Middle Aged | 13 | 2020 | 16342 | 0.210 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2020 | 27 | 0.200 |
Why?
|
| Logistic Models | 5 | 2019 | 1237 | 0.200 |
Why?
|
| Hearing Loss | 2 | 2020 | 45 | 0.200 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 5128 | 0.190 |
Why?
|
| Quality of Life | 5 | 2019 | 1138 | 0.190 |
Why?
|
| Female | 15 | 2020 | 30779 | 0.180 |
Why?
|
| Age Factors | 3 | 2019 | 1504 | 0.170 |
Why?
|
| Presbycusis | 1 | 2020 | 6 | 0.170 |
Why?
|
| Protective Factors | 1 | 2020 | 33 | 0.170 |
Why?
|
| Smell | 2 | 2017 | 26 | 0.160 |
Why?
|
| Cadmium | 1 | 2019 | 12 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2020 | 3072 | 0.160 |
Why?
|
| Auditory Threshold | 2 | 2020 | 26 | 0.160 |
Why?
|
| Vision Disorders | 1 | 2019 | 59 | 0.160 |
Why?
|
| Biomarkers | 3 | 2020 | 1306 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 903 | 0.150 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2018 | 77 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2019 | 71 | 0.150 |
Why?
|
| Incidence | 3 | 2019 | 1239 | 0.150 |
Why?
|
| Hot Flashes | 1 | 2018 | 94 | 0.140 |
Why?
|
| Vision, Ocular | 1 | 2017 | 18 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hearing | 1 | 2017 | 31 | 0.140 |
Why?
|
| Adult | 10 | 2020 | 15704 | 0.130 |
Why?
|
| Young Adult | 5 | 2019 | 4277 | 0.130 |
Why?
|
| Male | 11 | 2020 | 27794 | 0.130 |
Why?
|
| Humans | 16 | 2020 | 59479 | 0.130 |
Why?
|
| Women's Health | 1 | 2018 | 360 | 0.130 |
Why?
|
| Menopause | 1 | 2018 | 249 | 0.130 |
Why?
|
| Risk Factors | 5 | 2019 | 4991 | 0.120 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2014 | 10 | 0.120 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 24 | 0.120 |
Why?
|
| Aspirin | 1 | 2016 | 167 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 30 | 0.120 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 46 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2014 | 62 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 202 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2020 | 2377 | 0.110 |
Why?
|
| Time Factors | 2 | 2014 | 3619 | 0.110 |
Why?
|
| Dry Eye Syndromes | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 46 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 674 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 159 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2014 | 309 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 215 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 169 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 748 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2516 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2019 | 1927 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 789 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 587 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1168 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 372 | 0.090 |
Why?
|
| Brain | 1 | 2019 | 1493 | 0.090 |
Why?
|
| Health Promotion | 1 | 2014 | 471 | 0.090 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 48 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2010 | 135 | 0.080 |
Why?
|
| Contraindications | 1 | 2008 | 46 | 0.070 |
Why?
|
| Menstruation Disturbances | 1 | 2008 | 18 | 0.070 |
Why?
|
| Pregnancy, Unplanned | 1 | 2008 | 22 | 0.070 |
Why?
|
| Uterine Hemorrhage | 1 | 2008 | 20 | 0.070 |
Why?
|
| Equipment Failure | 1 | 2008 | 63 | 0.070 |
Why?
|
| United States | 5 | 2020 | 7431 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2008 | 115 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1099 | 0.070 |
Why?
|
| Device Removal | 1 | 2008 | 64 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2341 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 141 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 78 | 0.070 |
Why?
|
| Prevalence | 3 | 2019 | 1260 | 0.070 |
Why?
|
| Nurse's Role | 1 | 2008 | 116 | 0.070 |
Why?
|
| Nurse Practitioners | 1 | 2008 | 113 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 330 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 163 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 203 | 0.070 |
Why?
|
| Counseling | 1 | 2008 | 350 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1119 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 453 | 0.060 |
Why?
|
| Sex Factors | 2 | 2019 | 938 | 0.050 |
Why?
|
| Dementia | 2 | 2016 | 248 | 0.050 |
Why?
|
| Aldosterone | 1 | 2020 | 17 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 33 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 31 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2019 | 13 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 83 | 0.040 |
Why?
|
| Lead | 1 | 2019 | 41 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 18 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2019 | 52 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 56 | 0.040 |
Why?
|
| Vitamin D | 1 | 2019 | 132 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 554 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 171 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2017 | 146 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 122 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1080 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1483 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 244 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 250 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2014 | 117 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 208 | 0.020 |
Why?
|
| Olfactory Perception | 1 | 2011 | 3 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 10 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 2011 | 9 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 288 | 0.020 |
Why?
|
| Self Report | 1 | 2014 | 359 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 426 | 0.020 |
Why?
|
| Income | 1 | 2011 | 157 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 35 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 74 | 0.020 |
Why?
|
| Posture | 1 | 2010 | 127 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 129 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 99 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 242 | 0.020 |
Why?
|
| Movement | 1 | 2010 | 149 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 136 | 0.020 |
Why?
|
| Schools | 1 | 2010 | 150 | 0.020 |
Why?
|
| Gait | 1 | 2010 | 114 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6088 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 556 | 0.020 |
Why?
|